Digest Network Come funziona
Network
/
Società
So
Non verificato

Sound Pharmaceuticals

Di cosa scriviamo

BiotecnologiaEventiFarmaceuticaMedicina - VarieSalute

6 comunicati stampa

Guarda tutti i comunicati
01/12/2025
Igiene alimentare
Salute
Medicina - Varie
Farmaceutica
Biotecnologia
Industria
Sound Pharmaceuticals Receives FDA Breakthrough Therapy Designation for SPI-1005 to Treat Meniere’s Disease
Fonte
Sound Pharmaceuticals
Emittente
Business Wire
1.00
0
08/07/2025
Scienza
Biotecnologia
Farmaceutica
Salute
Medicina - Varie
Sanità
Eventi
Web e Social Network
Sound Pharma to Present at Upcoming Life Sciences Industry Conferences
Fonte
Sound Pharmaceuticals
Emittente
Business Wire
1.00
0
08/04/2025
Eventi
Biotecnologia
Salute
Scienza
Farmaceutica
Sound Pharma to Present at Upcoming Life Science Investor Conferences
Fonte
Sound Pharmaceuticals
Emittente
Business Wire
1.00
0
18/02/2025
Eventi
Fiere
Industria
Salute
Medicina - Varie
Sanità
Farmaceutica
Biotecnologia
Sound Pharma to Present SPI-1005 Preclinical and Clinical Hearing Loss and Tinnitus Data at the Defense Health Agency Hearing Center of Excellence Symposia and ARO MWM
Fonte
Sound Pharmaceuticals
Emittente
Business Wire
1.00
0
10/12/2024
Biotecnologia
Farmaceutica
Salute
Medicina - Varie
Eventi
Fiere
Industria
Sound Pharma Announces Positive Phase 3 Results for the Treatment of Meniere’s Disease with SPI-1005
Fonte
Sound Pharmaceuticals
Emittente
Business Wire
1.00
0
31/07/2024
Tecnica
Medicina - Varie
Video
Biotecnologia
Salute
Vetrine/Shopping
Farmaceutica
Sanità
Industria
Sound Pharma Announces Phase 3 Study Completion of SPI-1005 for the Treatment of Meniere’s Disease
Fonte
Sound Pharmaceuticals
Emittente
Business Wire
1.00
0

Recapiti

Social Media

Seguaci
0
Compatibilità
0